Active Ingredient(s): Glatiramer
FDA Approved: * December 20, 1996
Pharm Company: * TEVA
Category: Multiple Sclerosis

Glatiramer acetate (also known as Copolymer 1, Cop-1), sold under the brand name Copaxone among others, is an immunomodulator medication used to treat multiple sclerosis.[1][2] Glatiramer acetate is approved in the United States to reduce the frequency of relapses, but not for reducing the progression of disability. Observational studies, but not randomized controlled trials, suggest that it may reduce progression of disability. While a conclusive diagnosis of ... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
4 Discussions

Dosage List

Copaxone 20 mg/ml Subcutaneous Injection, Solution
NDC: 68546-317
Teva Neuroscience, Inc.
Copaxone 40 mg/ml Subcutaneous Injection, Solution
NDC: 68546-325
Teva Neuroscience, Inc.

Related Brands

Drugs with the same active ingredients